HPLC and GC–MS screening of Chinese proprietary medicine for undeclared therapeutic substances
- 7 March 2001
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 24 (5-6) , 983-992
- https://doi.org/10.1016/s0731-7085(00)00571-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Adulteration by Synthetic Therapeutic Substances of Traditional Chinese Medicines in TaiwanThe Journal of Clinical Pharmacology, 1997
- Monitoring the Safety of Chinese Herbal Medicines in Hong KongAnnals of Pharmacotherapy, 1996
- Usage and adverse effects of Chinese herbal medicinesHuman & Experimental Toxicology, 1996
- Complications resulting from the use of chinese herbal medications containing undeclared prescription drugsArthritis & Rheumatism, 1995
- Chinese herbal medicine induced acute renal failureArchives of internal medicine (1960), 1995
- Fatal accidental aconitine poisoning following ingestion of Chinese herbal medicine: a report of two casesForensic Science International, 1994
- Chinese herbal medicines revisited: a Hong Kong perspectiveThe Lancet, 1993
- Concise CommunicationsArthritis & Rheumatism, 1991
- Thin-layer chromatographic screening procedure for undeclared synthetic drugs in chinese herbal preparationsJournal of Chromatography A, 1985
- Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazoneJAMA, 1975